Why Hypercoagulation Develops
The syndrome is based on an imbalance in the blood coagulation system. There are four key mechanisms:
- Activation: excessive stimulation of factors responsible for coagulation and platelet aggregation.
- Accumulation: an increase in the concentration of procoagulants and proaggregants in the bloodstream.
- Deficiency: a decrease in the level or activity of natural anticoagulants and antiplatelet agents.
- Suppression: inhibition of the fibrinolytic system, preventing timely thrombus dissolution.
Trigger Clinical Conditions
Thrombotic syndrome rarely occurs in isolation. Most often, it accompanies systemic diseases:
- Cardiovascular: atherosclerosis and hypertension.
- Endocrine: diabetes mellitus, hypothyroidism, Cushing's syndrome.
- Critical Conditions: shock of various origins and endotoxemia.
Impact on Tissues and Organs
Thrombus formation blocks blood flow, causing circulatory hypoxia. Prolonged oxygen deprivation leads to:
- Dystrophic changes in cells.
- Decreased functional activity of organs.
- Tissue hypotrophy and hypoplasia.
Detachment of a venous thrombus poses a particular hazard. Entering the bloodstream, it turns into a thromboembolus, frequently resulting in occlusion of the pulmonary arteries (PE).
Briefly: answers to topical questions
Which specific natural anticoagulants decrease in the deficiency mechanism during thrombotic syndrome?
In the deficiency mechanism of thrombotic syndrome development, the level and/or activity of anticoagulants decreases.
Natural anticoagulants mentioned in the sources include:
- Antithrombin III.
- Protein C.
- Protein S.
Deficiency of antithrombin III, protein C, or protein S is a criterion for diagnosed thrombophilia. Nephrotic syndrome can cause urinary loss of natural anticoagulants—antithrombin III, proteins C, and S; plasminogen may also be lost along with them.
What specific concentrations of procoagulants and proaggregants increase in the accumulation mechanism?
During the accumulation mechanism in thrombotic syndrome, the concentration of procoagulants and proaggregants in the blood increases.
Procoagulants mentioned in the sources include:
- Fibrinogen.
- Coagulation factors V, VII, VIII, and X.
Proaggregants mentioned in the sources include:
- Thromboxane A₂.
- ADP.
- Prostaglandin F.
- Prostaglandin E.
- Catecholamines.
- Antibodies against blood cells.
What factors cause the suppression of the fibrinolytic system in thrombotic syndrome?
Suppression of the fibrinolytic system in thrombotic syndrome is caused by increased activity of fibrinolysis inhibitors.
Factors that inhibit thrombus dissolution include:
- Tissue plasminogen activator inhibitors — PAI-1 and PAI-2, which neutralize plasminogen activators.
- Antiplasmins — substances circulating in the blood that directly block the action of the active enzyme plasmin.
This imbalance prevents the lysis of the formed clot and promotes the progression of hypercoagulation.
Remember the "4-4-4" formula: 4 mechanisms of hypercoagulation, 4 groups of causes (vascular, endocrine, shock, toxic), and 4 types of tissue damage (hypoxia, dystrophy, decreased function, hypotrophy).
Class and exam questions
What is the main difference between thrombotic and hemorrhagic syndromes?
Thrombotic syndrome is characterized by excessive clotting and the risk of vascular occlusion, whereas hemorrhagic syndrome manifests as increased bleeding due to a deficiency in hemostatic factors.
Why is the risk of thrombosis increased in diabetes mellitus?
Diabetes mellitus creates conditions that disrupt the balance of hemostatic factors, shifting it toward hypercoagulation and reduced activity of the fibrinolytic system.
What is circulatory hypoxia in thrombosis?
This is a condition in which tissues suffer from oxygen deprivation because a thrombus physically blocks normal blood flow in an organ.
What else to study on this topic
- Detailed analysis of the molecular mechanisms of procoagulant activation.
- Comparative characteristics of venous and arterial thrombosis.
- The role of the vascular endothelium in regulating anticoagulant activity.
- Pathophysiological features of PE as a complication of thrombotic syndrome.
Master the entire topic in the "Pathophysiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Thrombotic syndrome" and 4,913 other pages for this subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 135 video lessons on the subject
Other topics in "Chapter 21. Typical Pathology Forms of the Blood System"
Free video lessons: pathophysiologyShort lessons with lecture notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.